Oleg V Averkov

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

St Segment Elevation Myocardial Infarction

Anti Inflammatory Drugs

End Stage Renal Disease

Prognostic Factors

Top Venues

Drug metabolism and personalized therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia P Denisenko, Anna S Zhiryakova, Ivan V Sychev, Alexander V Kryukov, Svetlana N Tuchkova, Olga Y Vakulenko, Oleg V Averkov, Valery I Vechorko, Karin Badavievich Mirzaev, Dmitry Alekseevich Sychev
Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs. Drug metabolism and personalized therapy 39 (2) (2024)
Natalia P Denisenko, Anna S Zhiryakova, Ivan V Sychev, Alexander V Kryukov, Svetlana N Tuchkova, Olga Y Vakulenko, Oleg V Averkov, Valery I Vechorko, Karin Badavievich Mirzaev, Dmitry Alekseevich Sychev
Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs. Drug metabolism and personalized therapy (2024)
Frans J Van de Werf, Arsen D Ristić, Oleg V Averkov, Alexandra Arias-Mendoza, Yves Lambert, José Francisco Kerr Saraiva, Pablo Sepulveda, Fernando Rosell-Ortiz, John Kerswell French, Ljilja B Musić, Katleen Vandenberghe, Kris Bogaerts, Cynthia M Westerhout, Alain Pagès, Thierry Danays, Kevin R Bainey, Peter Sinnaeve, Patrick Goldstein, Robert C Welsh, Paul W Armstrong, null null
Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction in STREAM-2: A Randomized, Open-Label Trial. Circulation (2023)